A study to explore the role of IDH1 (R132) mutation on Imatinib toxicity and effect of ABCG2/OCT1 expression on N-desmethyl imatinib plasma level in Egyptian Chronic Myeloid Leukemia Patients

Citation:
Alaa Fawzi, M. Omran;, R. Abdelfatah;, S. Abdelfatah;, R. Allam, and S. Shouman, "A study to explore the role of IDH1 (R132) mutation on Imatinib toxicity and effect of ABCG2/OCT1 expression on N-desmethyl imatinib plasma level in Egyptian Chronic Myeloid Leukemia Patients ", Drug research., 2023.